首页 | 本学科首页   官方微博 | 高级检索  
     


Clinical characteristics and genetic analysis in women with premature ovarian insufficiency
Authors:Eleonora Ferrarini  Laura Russo  Franca Fruzzetti  Patrizia Agretti  Giuseppina De Marco  Antonio Dimida  Elena Gianetti  Tommaso Simoncini  Paolo Simi  Fulvia Baldinotti  Elena Benelli  Enrico Pucci  Aldo Pinchera  Paolo Vitti  Massimo Tonacchera
Affiliation:1. Department of Endocrinology, Research Center of Excellence AmbiSEN, University of Pisa, Pisa, Italy;2. Department of Reproductive Medicine and Child Development, Division of Obstetrics and Gynecology, University of Pisa, Pisa, Italy;3. Mother and Child Department, Cytogenetics and Molecular Genetic Unit, University Hospital of Pisa, Pisa, Italy;1. Drug Development Research Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 33-94 Enoki-cho, Suita, Osaka 564-0053, Japan;2. Research Planning & Intelligence, Sumitomo Dainippon Pharma Co., Ltd., 33-94 Enoki-cho, Suita, Osaka 564-0053, Japan;3. Innovative Drug Discovery Laboratories, Sumitomo Dainippon Pharma Co., Ltd., 33-94 Enoki-cho, Suita, Osaka 564-0053, Japan;1. Center for the Study of Atherosclerosis, Bassini Hospital, Cinisello Balsamo, Milan, Italy;2. Department of Pharmacological and Biomolecular Sciences, Università degli Studi di Milano, Milan, Italy;3. Dipartimento di Medicina Interna, Centro Studi Malattie Metaboliche del Fegato – Cà Granda IRCCS Fondazione Ospedale Policlinico, Milan, Italy;4. William Harvey Research Institute, Barts and The London School of Medicine & Dentistry Queen''s Mary University, London, United Kingdom;5. Multimedica Hospital – IRCCS, Sesto San Giovanni, Milan, Italy;1. Prince of Wales Clinical School, University of New South Wales, Sydney, Australia;2. School of Medical Sciences, University of New South Wales, Sydney, Australia;3. St Elisabeth Ziekenhuis, Tilburg, The Netherlands;4. Department of Geriatrics, Neurosciences and Orthopaedics, Università Cattolica del Sacro Cuore, Rome, Italy;5. Don Gnocchi Foundation, Milan, Italy;6. St Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia;7. Brain and Mind Centre, University of Sydney, Sydney, Australia;1. Radiology Unit, Department of Diagnostic Imaging, Radiant and Metabolic Therapy, “Istituto Nazionale Tumori Fondazione Giovanni Pascale – IRCCS”, Naples, Italy;2. Department of Advanced Biomedical Sciences, Federico II University of Naples, Naples, Italy;3. Pathology Unit, Department of Diagnostic and Laboratory Pathology, “Istituto Nazionale Tumori Fondazione Giovanni Pascale – IRCCS”, Naples, Italy;4. Senology Surgery Unit, Department of Senology, “Istituto Nazionale Tumori Fondazione Giovanni Pascale – IRCCS”, Naples, Italy;1. Department of Medicine, UOC Hypertension and Nephrology, Policlinico Tor Vergata, Rome, Italy;2. Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands;3. Laboratory Cardiovascular Sciences, National Institute on Aging (NIA), NIH, Baltimore, USA;4. Centre of Cardiology and Angiology, Vilnius University Hospital Santari?ki? Klinikos, Vilnius, Lithuania;5. Department of Aging and Age-associated Diseases Prevention, National Research Center for Preventive Medicine, Moscow, Russian Federation;6. Department of Public Health - and Cardiovascular Research Center, National Yang-Ming University, Taipei, Taiwan;7. Department of Preventive Medicine, Chosun University Medical School, Gwangju, Republic of Korea;8. Institute of Genetics and Biomedic Research (IRGB), Consiglio Nazionale delle Ricerche, Monserrato, Cagliari, Italy;9. Bimetra, Clinical Research Center Ghent, Ghent University Hospital, Ghent, Belgium;10. DZHK (German Center for Cardiovascular Research), partner site Greifswald, Germany;11. Department of Internal Medicine B, University Medicine Greifswald, Germany;12. Department of Clinical Sciences, Lund University, University Hospital, Malmö, Sweden;13. Department of Neurology & Research Institute of Clinical Medicine, Chobuk National University-Biomedical Institute of Chonbuk National University Hospital, Jeonju, Republic of Korea;14. Department of Preventive Medicine, Chonnam National University Medical School, Gwangju, Republic of Korea;15. Clinical Chemistry, AZ Saint-Jan Bruges Hospital, Asklepios Core Lab, And Department of Cardiovascular Diseases, Ghent University, Ghent, Belgium;p. Department of Preventive Medicine & Institute of Wonkwang Medical Science, Wonkwang University College of Medicine, Iksan, Republic of Korea;q. Loyola College, Baltimore, USA;r. Department of Preventive Medicine, Seonam University College of Medicine, Namwon, Republic of Korea;s. Laboratory of Genetics, National Institute on Aging (NIA), NIH, Baltimore, USA
Abstract:ObjectivePremature ovarian insufficiency (POI) is defined as a primary ovarian defect characterized by absent menarche (primary amenorrhea) or premature depletion of ovarian follicles before the age of 40 (secondary amenorrhea) with hypergonadotropism and hypoestrogenism.MethodsWe studied the clinical, biological, and genetic data related to 50 POI patients with a mean age of menopause of 29 years (94% with secondary amenorrhea, 6% with primary amenorrhea and 15% with a family history of POI). Seventeen patients were affected by endocrine autoimmune diseases, antral follicles were observed in 31 patients by ultrasonography.ResultsKaryotype analysis did not show any abnormality of the X chromosome. No mutation in FSH receptor and GDF-9 genes was reported, while in one patient a variant of BMP-15 gene (A180T) was found. Four patients had fragile X mental retardation 1 gene (FMR1) premutation and one an intermediate sized CGG repeats of the same gene. Two patients with FMR1 premutation were sister and developed secondary amenorrhea at the age of 34 and 37 years. The other two patients presented with oligoamenorrhea at the age of 39 and 34 years. The patient harboured the intermediate sized CGG repeats developed secondary amenorrhea at the age of 33 years.ConclusionsThe genetic analysis performed on a cohort of patients with POI revealed that 8% had FMR1 premutation and only one patient a previously known variant of BMP-15 gene. No alteration of the karyotype and FSH receptor and GDF-9 genes was evidenced.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号